Comparative analysis of clinical outcomes and safety profile of trientine and d-penicillamine in the management of Wilson’s disease: A systematic review and meta-analysis

Introduction: Wilson disease (WD) is a rare metabolic disorder of copper metabolism, requiring life-long therapy, usually with D-penicillamine or trientine. This review compares their clinical effectiveness and safety. Methodology: PubMed, Cochrane, Clinicaltrials.gov and WHO-ICTRP, along with other...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hafiz Muhammad Ehsan Arshad, Muhammad Zain Raza, Musab Maqsood, Muhammad Omais, Muhammad Hashim Faisal, Ali Ahmad Nadeem
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2025-01-01
coleção:	Rare
Assuntos:	Wilson disease Chelators Penicillamine Trientine Clinical efficacy Copper metabolism
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2950008725000213
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!